MTOR and neoplasm: Additionally, LMP2A has been shown to activate PI3K/Akt, leading to mTOR-mediated downstream inhibition of 4E-BP1 and upregulation of c-Myc, and plays a role in the formation of EBV-induced vasculogenic mimicry (tumor that mimics blood vessels) [45,46].